Singapore markets close in 5 hours 4 minutes
Straits Times Index
3,308.24 +11.35 (+0.34%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,403.89 +196.76 (+1.08%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,720.94 +2,238.78 (+3.89%) CMC Crypto 200
1,285.97 +15.23 (+1.20%)
REGN Dec 2025 1080.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:38AM EDT. Market open.
| Previous close | 83.90 |
| Open | 84.20 |
| Bid | 97.00 |
| Ask | 105.00 |
| Strike | 1,080.00 |
| Expiry date | 2025-12-19 |
| Day's range | 83.90 - 84.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
ZacksRegeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
ZacksRegeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Regeneron (REGN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GuruFocus.comRegeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
First Quarter Results Show Revenue Decline but Strong Dupixent and Libtayo Sales Growth
© 2024 Yahoo. All rights reserved.